{"id":395832,"date":"2020-12-08T16:08:42","date_gmt":"2020-12-08T21:08:42","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=395832"},"modified":"2020-12-08T16:08:42","modified_gmt":"2020-12-08T21:08:42","slug":"precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/","title":{"rendered":"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">GERMANTOWN, Md.<\/span>, <span class=\"xn-chron\">Dec. 8, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3006401-1&amp;h=1494781969&amp;u=https%3A%2F%2Fprecigen.com%2F&amp;a=Precigen%2C+Inc.\" rel=\"nofollow noopener noreferrer\">Precigen, Inc.<\/a>\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company will host a virtual event on <span class=\"xn-chron\">Tuesday, December 15, 2020<\/span> at <span class=\"xn-chron\">11:00 AM ET<\/span> to provide an update on the latest progress for its clinical pipeline. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg\" title=\"Precigen Logo (PRNewsfoto\/Precigen, Inc.)\" alt=\"Precigen Logo (PRNewsfoto\/Precigen, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The event will showcase data from several of the Company&#8217;s most advanced clinical programs, such as PRGN-3005 UltraCAR-T<sup>\u00ae<\/sup>, PRGN-3006 UltraCAR-T<sup>\u00ae<\/sup> and AG019 ActoBiotics<sup>TM<\/sup>. Precigen executives and key opinion leaders will participate in the event, including:<\/p>\n<ul type=\"disc\">\n<li>\n          <span class=\"xn-person\">Helen Sabzevari<\/span>, PhD, President and CEO of Precigen <\/li>\n<li>\n          <span class=\"xn-person\">Pieter Rottiers<\/span>, PhD, CEO of Precigen ActoBio <\/li>\n<li>\n          <span class=\"xn-person\">Mary L. (Nora) Disis<\/span>, MD, faculty member at the <span class=\"xn-org\">University of Washington<\/span> and Fred Hutchinson Cancer Research Center and one of the lead investigators for the PRGN-3005 clinical study <\/li>\n<li>\n          <span class=\"xn-person\">Kevan Herold<\/span>, MD, Professor of Immunobiology and of Medicine (Endocrinology) at <span class=\"xn-org\">Yale School of Medicine<\/span> and one of the lead investigators for the AG019 clinical study<\/li>\n<\/ul>\n<p>Participants may register and access the live webcast through Precigen&#8217;s investor relations website in the <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3006401-1&amp;h=814285360&amp;u=https%3A%2F%2Finvestors.precigen.com%2Fpress-and-events&amp;a=Press+%26+Events\" rel=\"nofollow noopener noreferrer\">Press &amp; Events<\/a>\u00a0section. An archived recording will be posted to the investor relations website following the event.<\/p>\n<p>\n        <b>Precigen: Advancing Medicine with Precision<sup>\u2122<br \/><\/sup><\/b>Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization. For more information about Precigen, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3006401-1&amp;h=314658157&amp;u=http%3A%2F%2Fwww.precigen.com%2F&amp;a=www.precigen.com\" rel=\"nofollow noopener noreferrer\">www.precigen.com<\/a> or follow us on Twitter <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3006401-1&amp;h=2376504338&amp;u=https%3A%2F%2Ftwitter.com%2Fprecigen&amp;a=%40Precigen\" rel=\"nofollow noopener noreferrer\">@Precigen<\/a> and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3006401-1&amp;h=1051832366&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fprecigen%2F&amp;a=LinkedIn\" rel=\"nofollow noopener noreferrer\">LinkedIn<\/a>.<\/p>\n<p>\n        <b>Trademarks<br \/><\/b>Precigen, Advancing Medicine with Precision, UltraCAR-T, and ActoBiotics are trademarks of Precigen and\/or its affiliates. Other names may be trademarks of their respective owners.<\/p>\n<p>\n        <b>Cautionary Statement Regarding Forward-Looking Statements<br \/><\/b>Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon the Company&#8217;s current expectations and projections about future events and generally relate to plans, objectives, and expectations for the development of the Company&#8217;s business, including the timing and progress of preclinical studies, clinical trials, discovery programs and related milestones, the promise of the Company&#8217;s portfolio of therapies, and in particular its CAR-T therapies, and the Company&#8217;s refocus to a healthcare-oriented business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties, including the possibility that the timeline for the Company&#8217;s clinical trials might be impacted by the COVID-19 pandemic, and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For further information on potential risks and uncertainties, and other important factors, any of which could cause the Company&#8217;s actual results to differ from those contained in the forward-looking statements, see the section entitled &#8220;Risk Factors&#8221; in the Company&#8217;s most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.<\/p>\n<p>\n        <b>For more information, contact:<\/b>\n      <\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" class=\"prntblns\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Investor Contact:<\/b><br \/>\n                <\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Steven Harasym<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Vice President, Investor Relations<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Tel: +1 (301) 556-9850<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:investors@precigen.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">investors@precigen.com<\/a> \u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Media Contact:<\/b><br \/>\n                <\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Glenn Silver <\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Lazar-FINN Partners<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:glenn.silver@finnpartners.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">glenn.silver@finnpartners.com<\/a>\u00a0<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17295&amp;sd=2020-12-08\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments-301188801.html\">http:\/\/www.prnewswire.com\/news-releases\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments-301188801.html<\/a><\/p>\n<p>SOURCE  Precigen, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY17295&amp;Transmission_Id=202012081605PR_NEWS_USPR_____NY17295&amp;DateId=20201208\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire GERMANTOWN, Md., Dec. 8, 2020 \/PRNewswire\/ &#8212;\u00a0Precigen, Inc.\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company will host a virtual event on Tuesday, December 15, 2020 at 11:00 AM ET to provide an update on the latest progress for its clinical pipeline. The event will showcase data from several of the Company&#8217;s most advanced clinical programs, such as PRGN-3005 UltraCAR-T\u00ae, PRGN-3006 UltraCAR-T\u00ae and AG019 ActoBioticsTM. Precigen executives and key opinion leaders will participate in the event, including: Helen Sabzevari, PhD, President and CEO of Precigen Pieter Rottiers, PhD, CEO of Precigen ActoBio Mary L. (Nora) Disis, MD, faculty member at the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-395832","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire GERMANTOWN, Md., Dec. 8, 2020 \/PRNewswire\/ &#8212;\u00a0Precigen, Inc.\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company will host a virtual event on Tuesday, December 15, 2020 at 11:00 AM ET to provide an update on the latest progress for its clinical pipeline. The event will showcase data from several of the Company&#8217;s most advanced clinical programs, such as PRGN-3005 UltraCAR-T\u00ae, PRGN-3006 UltraCAR-T\u00ae and AG019 ActoBioticsTM. Precigen executives and key opinion leaders will participate in the event, including: Helen Sabzevari, PhD, President and CEO of Precigen Pieter Rottiers, PhD, CEO of Precigen ActoBio Mary L. (Nora) Disis, MD, faculty member at the &hellip; Continue reading &quot;Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T21:08:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments\",\"datePublished\":\"2020-12-08T21:08:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/\"},\"wordCount\":618,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/\",\"name\":\"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\",\"datePublished\":\"2020-12-08T21:08:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/","og_locale":"en_US","og_type":"article","og_title":"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments - Market Newsdesk","og_description":"PR Newswire GERMANTOWN, Md., Dec. 8, 2020 \/PRNewswire\/ &#8212;\u00a0Precigen, Inc.\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company will host a virtual event on Tuesday, December 15, 2020 at 11:00 AM ET to provide an update on the latest progress for its clinical pipeline. The event will showcase data from several of the Company&#8217;s most advanced clinical programs, such as PRGN-3005 UltraCAR-T\u00ae, PRGN-3006 UltraCAR-T\u00ae and AG019 ActoBioticsTM. Precigen executives and key opinion leaders will participate in the event, including: Helen Sabzevari, PhD, President and CEO of Precigen Pieter Rottiers, PhD, CEO of Precigen ActoBio Mary L. (Nora) Disis, MD, faculty member at the &hellip; Continue reading \"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-08T21:08:42+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments","datePublished":"2020-12-08T21:08:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/"},"wordCount":618,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/","name":"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","datePublished":"2020-12-08T21:08:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-host-rd-update-virtual-event-on-december-15th-to-share-latest-clinical-developments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Precigen to Host R&amp;D Update Virtual Event on December 15th to Share Latest Clinical Developments"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=395832"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395832\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=395832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=395832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=395832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}